FOLD - AMICUS THERAPEUTICS, INC.
14.33
-0.010 -0.070%
Share volume: 5,574,104
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$14.34
-0.01
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-06-2024 | 02-19-2025 | 05-01-2025 | 07-31-2025 | 11-04-2025 | 02-20-2026 | |
| Total revenue | 110.403 M | 126.669 M | 141.517 M | 149.706 M | 125.249 M | 154.688 M | 169.061 M | 185.212 M | |
| Cost of revenue | 13.567 M | 11.261 M | 13.279 M | 14.836 M | 11.698 M | 15.217 M | 19.467 M | 26.547 M | |
| Gross profit | 96.836 M | 115.408 M | 128.238 M | 134.870 M | 113.551 M | 139.471 M | 149.594 M | 158.665 M | |
| 19.18% | 11.12% | 5.17% | -15.81% | 22.83% | 7.26% | 6.06% | |||
| Operating expenses | 116.358 M | 98.259 M | 101.266 M | 116.858 M | 119.666 M | 145.391 M | 113.451 M | 140.822 M | |
| Selling general and admin | 88.029 M | 73.576 M | 75.106 M | 86.668 M | 91.827 M | 84.543 M | 90.036 M | 117.081 M | |
| Research and development | 28.329 M | 24.683 M | 26.160 M | 30.190 M | 27.839 M | 60.848 M | 23.415 M | 23.741 M | |
| Total expenses | 124.557 M | 100.441 M | 106.579 M | 118.899 M | 121.503 M | 148.945 M | 115.325 M | 142.719 M | |
| -19.36% | 6.11% | 11.56% | 2.19% | 22.59% | -22.57% | 23.75% | |||
| Operating income | -27.721 M | 14.967 M | 21.659 M | 15.971 M | -7.952 M | -9.474 M | 34.269 M | 15.946 M | |
| Ebit | -32.687 M | 11.250 M | 18.396 M | 18.476 M | -7.402 M | -8.459 M | 45.156 M | 13.738 M | |
| Pretax income | -43.583 M | 108.000 K | 6.785 M | 7.934 M | -18.045 M | -19.181 M | 34.274 M | 3.143 M | |
| -100.25% | 6,182.41% | 16.93% | -327.44% | 6.30% | -278.69% | -90.83% | |||
| Income tax | 4.836 M | 15.805 M | 13.514 M | -6.805 M | 3.641 M | 5.239 M | 16.968 M | 1.453 M | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -48.419 M | -15.697 M | -6.729 M | 14.739 M | -21.686 M | -24.420 M | 17.306 M | 1.690 M | |
| 67.58% | 57.13% | 319.04% | -247.13% | -12.61% | 170.87% | -90.23% |